A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients

• Dominique L. Braun ,

  * E-mail: jan.fehr@usz.ch (JF); dominique.braun@usz.ch (DLB)

  Affiliations Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

  ⨯
• Andri Rauch,

  Affiliation Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland

  ⨯
• Manel Aouri,

  Affiliation Division of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland

  ⨯
• Nina Durisch,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Nadia Eberhard,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Alexia Anagnostopoulos,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Bruno Ledergerber,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Beat Müllhaupt,

  Affiliation Clinic for Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Karin J. Metzner,

  Affiliations Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

  ⨯
• Laurent Decosterd,

  Affiliation Division of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland

  ⨯
• Jürg Böni,

  Affiliation Swiss National Center for Retroviruses, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

  ⨯
• Rainer Weber,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Jan Fehr ,

  * E-mail: jan.fehr@usz.ch (JF); dominique.braun@usz.ch (DLB)

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  ⨯
• Swiss HIV Cohort Study

  ¶Members of the Swiss HIV Cohort Study are listed in the Acknowledgments.

  ⨯